RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
60 hedge funds and large institutions have $297M invested in Ra Pharmaceuticals, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
25% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 20
Holders
60
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$6.98M | |
| 2 | +$4.79M | |
| 3 | +$3.89M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.63M |
| 5 |
EU
Emory University
Atlanta,
Georgia
|
+$2.21M |
Top Sellers
| 1 | -$3.1M | |
| 2 | -$2.77M | |
| 3 | -$1.48M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$1.38M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.21M |